Zimmer Biomet Holdings IncZBH:NYQ

1.25 / 1.09%
Close in USDToday's changeShares traded1 year changeBeta
Data delayed at least 15 minutes, as of May 05 2016 21:00 BST.


On Thursday, Zimmer Biomet Holdings Inc (ZBH:NYQ) closed at 115.94, 1.55 % below its 52-week high of 117.77, set on Apr 28, 2016.

52-week range
Feb 12 2016
Apr 28 2016
Markit short selling activity
Day high115.97
Day low114.27
Previous close114.69
Average volume1.41m
Shares outstanding198.85m
Free float198.37m
P/E (TTM)160.51
Market cap22.85bn USD
EPS (TTM)0.7159 USD
Annual div (IAD)0.96 USD
Annual div yield (IAD)0.84%
Div ex-dateMar 29 2016
Div pay-dateApr 29 2016
Data delayed at least 15 minutes, as of May 05 2016 21:00 BST.

Comparative analysis

Past 90 days
1 week1 month6 months1 year5 years
Zimmer Biomet Holdings Inc+0.82 %+9.40 %+7.50 %+4.91 %+74.82 %
S&P 500 INDEX-1.19 %+0.29 %-2.32 %-1.83 %+53.63 %
USA/HEALTH CARE-1.23 %+2.09 %-3.42 %-4.23 %+49.78 %
USA/H CARE EQUIP&SUPPL-1.22 %+3.68 %+5.09 %+6.84 %+41.67 %
Data delayed at least 15 minutes, as of May 05 2016 21:00 BST.
© Thomson Reuters Click for restrictions.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.